Published in Ross Fiziol Zh Im I M Sechenova on August 01, 2003
Hypothalamic mechanisms of ageing and of specific age pathology--II. on the sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in adaptive homestasis. Exp Gerontol (1979) 1.39
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol (2004) 1.08
Glucose-induced effects and joker function of glucose: endocrine or genotoxic prevalence? Horm Metab Res (2006) 0.99
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol (2003) 0.94
Preliminary evidence on metabolic rehabilitation of cancer patients. Arch Geschwulstforsch (1988) 0.91
CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol (2001) 0.87
Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med (2003) 0.84
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84
[Aromatase (estrogen synthetase) gene expression in human leukocytes]. Ross Fiziol Zh Im I M Sechenova (2000) 0.79
Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma (1997) 0.79
[A polymorphism study of the CYP19 gene in endometrial cancer patients]. Vopr Onkol (2000) 0.79
Endocrine-metabolic criteria for distinguishing two pathogenetic types of breast cancer. Neoplasma (1977) 0.78
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol (2000) 0.77
[Polymorphism of glucose intolerance and insulin resistance susceptibility genes in oncological patients]. Mol Biol (Mosk) (2009) 0.77
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77
Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences. Eur J Gynaecol Oncol (1993) 0.76
Hormone-metabolic status in moderately smoking breast cancer patients. Acta Oncol (1997) 0.76
Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione. Int J Cancer (1998) 0.76
[Cognitive function in patients with endometrial and colorectal cancer: connection with hormonal and metabolic status]. Vopr Onkol (2004) 0.76
Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears. J Cancer Res Clin Oncol (2002) 0.76
[Features of carcinogenesis and aging in knockout male mice PARP-1]. Vopr Onkol (2010) 0.76
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76
Induction of the estrogen effect-switching phenomenon by ethanol and its correction. Neurosci Behav Physiol (2002) 0.76
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients. Mutat Res (1996) 0.75
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
Professor Vladimir Dilman. Int J Obes Relat Metab Disord (1995) 0.75
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis]. Vopr Onkol (1972) 0.75
[Endocrine-genotoxic switchings as promoter of main noninfectious diseases]. Vestn Ross Akad Med Nauk (2008) 0.75
[Effect of tobacco smoke on the level of estrogens and DNA in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
[Gail coefficient as a risk factor and prognosticator for the course of breast cancer: correlation with hormonal and metabolic parameters and clinical and morphologic features]. Vopr Onkol (2008) 0.75
Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer. Clin Exp Obstet Gynecol (1990) 0.75
[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75
[Determination of the proliferative activity of breast cancer cells using 5-bromo-2'-deoxyuridine in vivo]. Vopr Onkol (1997) 0.75
[Estrogen-dependence of thyroid carcinoma: testing with estradiol preparations and tamoxifen]. Vopr Onkol (2008) 0.75
[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75
[Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): association with clinical and biological characteristics of breast cancer]. Vopr Onkol (2008) 0.75
[Physiologico-hygienic assessment of visual work in reading microfilm]. Gig Tr Prof Zabol (1968) 0.75
Study of tobacco smoke influence on content of estrogens and DNA flow cytometry data in uterine tissue of rats of different age. Horm Metab Res (1999) 0.75
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[Decrease of testosterone level in blood of breast cancer patients of reproductive age after neoadjuvant chemotherapy]. Vopr Onkol (2012) 0.75
[Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer]. Vopr Onkol (1996) 0.75
[Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells]. Vopr Onkol (1998) 0.75
[Protocol of the 500th jubilee meeting of the Society of Oncologists, devoted to the theme of "Hormone-dependent tumors -- pathogenesis and therapy," May 12, 2014]. Vopr Onkol (2014) 0.75
[Steroid hormone excretion and some metabolic indices in children with breast hyperplasia]. Vopr Onkol (1973) 0.75
[Search for drugs which decrease the hypothalamic threshold of homeostatic inhibition. I. Results of studies of the product Agr-307. (1st conclusions)]. Agressologie (1971) 0.75
Influence of tobacco smoke on DNA unwinding and uterotrophic effect of estrogens in rats. Cancer Lett (1998) 0.75
[A study of the effect of tobacco smoke on the uterotropic effects of estrogens]. Biull Eksp Biol Med (1997) 0.75
[State of immunological reactivity in breast cancer patients receiving prednisolone treatment]. Vopr Onkol (1979) 0.75
[Hormonal status and the clinical course of ovarian cancer]. Akush Ginekol (Mosk) (1978) 0.75
[Effects of tamoxifen and oxyprogesterone caproate on steroid hormone receptors in tumors and indicators of reproductive homeostasis in patients with cancer of the uterine body]. Akush Ginekol (Mosk) (1988) 0.75
[Detection of substances lowering the hypothalamic threshold of homeostatic inhibition. III. Study of Agr 1240]. Agressologie (1977) 0.75
[Relation of urinary excretion of cholesterol in cancer patients to certain hormonal-metabolic parameters and the effect of drugs on this relation]. Vopr Med Khim (1979) 0.75
[Immunohistochemical study of the proliferation of breast cancer cells based on the expression of proliferating cell nuclear antigen (PCNA)]. Vopr Onkol (1998) 0.75
[Physiological and hygienic characteristics of visual work performed by stereophotogrammetry operators]. Gig Tr Prof Zabol (1973) 0.75
[Family diabetes and its consequences in cancer patients]. Vopr Onkol (2013) 0.75
[Molecular biological and biochemical features of breast cancer]. Vestn Ross Akad Med Nauk (1998) 0.75
[Postoperative hormone therapy of breast cancer (analysis of overall survival)]. Vopr Onkol (1996) 0.75
[Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[The effect of tobacco smoke on the uterotropic and genotoxic effects of estrogens in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1997) 0.75
[Evaluation of the effect of ovariectomy in patients with stage III breast cancer]. Vestn Khir Im I I Grek (1987) 0.75
[Steroid hormone receptors and survival in breast cancer patients]. Vopr Onkol (1986) 0.75
[The nature of hyperinsulinemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide]. Vopr Onkol (2000) 0.75
[Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence]. Vopr Onkol (2014) 0.75
[Induction by ethanol of 'phenomenon of switching estrogen effect' and its correction]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[Work conditions and the state of individual physiological functions in women telephone operators in an information referral service]. Gig Tr Prof Zabol (1973) 0.75
[Neovir, an interferon inductor, modifies expression of steroid hormone receptors in hormone-dependent tissues and restores sensitivity to tamoxifen in patients with inoperable breast cancer]. Vopr Onkol (1996) 0.75
[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75
[Parameters of estrogen expression in patients with endometrial tumors as prognostic signs of the effectiveness of neoadjuvant antitumor hormone therapy]. Vopr Onkol (1996) 0.75
[Tamoxifen-induced progesterone receptors in breast tumors]. Vopr Onkol (1991) 0.75
[Microviscosity of erythrocyte membranes in breast cancer patients: connection with the receptor phenotype of the tumor]. Vopr Onkol (2014) 0.75
Effect of ethanol on uterotropic action of estrogens. Bull Exp Biol Med (2000) 0.75
[Industrial hygiene requirements for working with microfilm]. Gig Sanit (1970) 0.75
[Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives]. Vopr Onkol (2010) 0.75